Archive: https://archive.today/IDoGQ
From the post:
>A woman treated with a pioneering type of immunotherapy for a solid tumour has been in remission for more than 18 years with no further treatments, experts have revealed. The therapy involves taking T-cells, a type of white blood cell, from a patient and genetically engineering them to target and kill cancer cells. These modified T-cells are grown in a laboratory and then infused back into the patient.
I'm a bit more interested in the CAR -NK studies. NK = natural killer cells. It's supposed to have less side effects than T cell CARs.
Good news. But remember pharma’s view- one cured patient is one less customer
(post is archived)